Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 40, Issue , 1997, Pages

  Ogura, Michinori ^a   Kagami, Yoshitoyo ^a   Suzuki, Ritsuro ^a   Miura, Kazuhisa ^a   Uehira, Kazutaka ^a   Kurokawa, Toshiro ^b   Ito, Tatsuya ^b   Kinoshita, Tomohiro ^b   Emi, Nobuhiko ^b   Morishima, Yasuo ^a   Kodera, Yoshihisa ^c   Ueda, Ryuzo ^d  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^d NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

CD34+ selection; High dose chemoradiotherapy; Immunomagnetic beads; Non Hodgkin's lymphoma; PBSCT

Indexed keywords

AMPHOTERICIN B; ANTINEOPLASTIC AGENT; ASPARAGINE; BETHANOID; CD34 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; MELPHALAN; MESNA; METHOTREXATE; MITOXANTRONE; PIRARUBICIN; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RETINOIC ACID; UNCLASSIFIED DRUG; VANCOMYCIN; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; CELL ISOLATION; CELL SEPARATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; INFECTION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; LYMPHOBLASTOMA; LYMPHOMA; MALE; MORTALITY; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PERIPHERAL BLOOD STEM CELL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; REMISSION; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; T CELL LEUKEMIA; TECHNIQUE; WHOLE BODY RADIATION;

EID: 0030740073     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051062     Document Type: Conference Paper

References (35)

1. Armitage JO (1989) Bone marrow transplantation in the treatment of patients with lymphoma. Blood 7:1749.
2. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B (1992) Isolation of a candidate human hematopoietic stem cell population. Proc Natl Acad Sci USA 89:2804
3. Berenson RJ, Bensinger WI, Kalamasz T, Schuening D, Deeg HJ, Graham T, Storb R (1987) Engraftment of dogs with 1a-positive marrow cells isolated by avidin-biotin immunoadsorption. Blood 69:1363
4. Berenson RJ, Andrews RG, Bensinger WI, Kalamasz D, Knitter G, Buckner CD, Bernstein JD (1988) Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951
5. Berenson RJ, Bensinger WI, Hill RS, Andrews G, Garcia-Lopez J, Kalamasz DF, Still BJ, Spieer G, Buckner CD, Bernstein ID, Thomas ED (1991) Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717
6. Berenson RJ, Andrews RG, Bensinger WI, Kalamasz DF, Hill RS, Still BJ, Weiden P, Shulman HM, Wamke R, Buckner CD, Bernstein ID (1994) Selection of CD34+ marrow cells for autologous marrow transplantation. Hematol Oncol Ann 2:78
7. Cabanillas F, Jagannath S, Philip T (1989) Management of recurrent or refractory disease. In: Magrath I (ed) Advances in lymphoma. National Cancer Institute, Washington, D.C., p 359
8. Civin CI, Trischmann T, Kadan NS, Davis J, Noga S, Cohen K, Duffy B, Groenewegen I, Wiley J, Law P, Hardwick A, Oldham F, Gee A (1996) Highly purified CD34-positive cells reconstitute hematopoiesis. J Clin Oncol 14:2224
9. Colombat P, Gorin NC, Lemonnier MP, Binet C, Laporte JP, Douay L, Desbois I, Lopez M, Lamagnere JP, Najman A (1990) The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas. J Clin Oncol 8:630
10. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM (1995) A clinical analysis of two indolent lymphoma entities: mantle-cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 85:1075
11. Fouillard L, Gorin NC, Laporte JP, Douay L, Lopez M, Isnard F, Jouet JP, Noel MP, Morel P, Fenaux P, Aoudjhane M, Stachowiak J, Devidas A, Bauters F, Najman A (1991) Feasibility of autologous bone marrow transplantation for early consolidation of follicular non-Hodgkin's lymphoma. Eur J Haematol 46:279
12. Freedman A, Rie J, Neuberg D, Anderson KC, Rabinowe SN, Mauch P, Takvorian T (1991) Autologous bone marrow transplantation in 69 patients with a history of low grade B cell non-Hodgkin's lymphoma. Blood 77:2524
13. Freedman AS, Gribben JG, Rabinowe S, Neuberg D, Mauch P, Spector N, Anderson K, Soiffer R, Pesek K, Robertson M, Whelan M, Ritz J, Nadler L (1993) Autologous bone marrow transplantation in advanced low grade B cell non-Hodgkin's lymphoma in first remission. Blood 82[Suppl 1]:332A (abstract)
14. Gorin NC, Lopez M, Laporte JP, Quittet P, Lesage S, Lemoine F, Berenson RJ, Isnard F, Grande M, Stachowiak J, Labopin M, Fouillard L, Morel P, Jouet JP, Walter MPN, Detourmignies L, Aoudjhane M, Bauters F, Najman A, Douay L (1995) Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 85:1647
15. Gribben JG, Freedman AS, Neuberg D, Denis SD, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler AM (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B cell lymphoma. N Engl J Med 325:1525
16. Gulati SC, Shank B, Black P, Yopp J, Kosiner B, Straus D, Filipa D, Kempin S, Castro-Malaspina H, Cunningham I (1988) Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. J Clin Oncol 8:1303
17. Hardwick AR, Kulcinski D, Mansour V, Ishisawa L, Law P, Gee AP (1992) Design of large scale separation systems for positive and negative selection of cells using superparamagnetic microspheres. J Hematother 1:379
18. International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987
19. Krause DS, Fackler MJ, Civin CI, May WS (1996) CD34: structure, biology and clinical utility. Blood 87:1
20. Kurokawa T, Kinoshita T, Ito T, Saito H, Hotta T (1996) Detection of minimal residual disease in B cell lymphoma by a PCR-mediated RNase protection assay. Leukemia 10:1222
21. Lebkowski JS, Schain LK, Okrongly D, Levinisky R, Harvey MJ, Okarma T (1992) Rapid isolation of human CD34 hematopoietic stem cells. Purging of human tumor cells. Transplantation 53:1011
22. Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphoma. Summary and description of a Working Formulation for clinical usage. Cancer 49:2112
23. Ogura M, Kagami Y, Suzuki R, Koike K, Tsuboi K, Uehira K, Ariyoshi Y, Ogawa M (1996) Mobilizing effect of peripheral blood stem cells by biweekly CHOP therapy with G-CSF for aggressive non-Hodgkin's lymphoma patients. Ann Oncol 7:172 (abstract)
24. Philip T, Armitage JO, Spitzer G, Chauvin R, Jagannath S, Cahn JY, Colombat P, Goldstone AH, Gorin NC, Flesh M, Laporte JPh, Maraninchi D, Pico J, Bosly A, Anderson C, Schots R, Biron P, Cabanillas F, Dicke K (1987) High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non Hodgkin's lymphoma. N Engl J Med 316:1493
25. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van Der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harousseau JL, Coiffier B, Biron P, Mandelli F, Chauvin F (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540
26. Rohatiner AZS, Freedman AS, Nadler L, Lim J, Lister TA (1994) Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma. Ann Oncol 5 (Suppl):143
27. Schiller G, Vescio R, Freytes C, Spitzer G, Sahebi F, Lee M, Hua Wu C, Cao J, Lee JC, Hong CH, Lichtenstein A, Lill M, Hall J, Berenson R, Berenson J (1995) Transplantation of CD34+ peripheral blood progenitor cells after high dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390
28. Shimoyama M et al. (1988) The Lymphoma Study Group (1981-1983). Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. J Clin Oncol 6:1088
29. Shpall EJ, Ball ED, Champlin RE, Le Maistre CF, Holland HK, Saral R, Hoffman E, Berenson RJ (1993) A prospective randomized phase III study using the Ceprate SC stem cell concentrator to isolate CD34+ hematopoietic progenitors for autologous marrow transplantation after high dose chemotherapy. Blood 82[Suppl 1]:83a (abstract)
30. Shpall EJ, Jones RB, Franklin WA, Archer PG, Cunel T, Bitter M, Claman H, Beamman S, Stemmer S, Purdy M, Myers S, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ (1994) Transplantation of enriched CD34+ autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34+ peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 12:28
31. Takvorian T, Canellos GP, Ritz J, Freeman AS, Anderson KC, Mauch P, Tarbell N, Coral F, Daley H, Yeap B, Schlossman SF, Nadler LM (1987) Prolonged disease free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med 316:1499
32. Teodorovic I, Pittaluga S, Kluin-Nelemans JC, Meerwalut JH, Hagenbeek A, Glabbeke M van, Somers R, Bijnens L, Noordijk EM, De Wolf Peeters C for the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group (1995) Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. J Clin Oncol 13:2819
33. Terstappen LWMM, Huang S, Safford M, Lansdorp PM, Loken MR (1991) Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+/CD38- progenitor cells. Blood 77:1218
34. Tobinai K et al. (1993) Toxicity grading criteria of the Japan Clinical Oncology Group. Jpn J Clin Oncol 23:250
35. Veelken H, Tycko B, Sklar J (1991) Sensitive detection of clonal antigen receptor gene rearrangements for the diagnosis and monitoring of lymphoid neoplasms by a polymerase chain reaction-mediated ribonuclease protection assay. Blood 78:1318